Molybdenum cluster loaded PLGA nanoparticles: An innovative theranostic approach for the treatment of ovarian cancer

N. Brandhonneur, T. Hatahet, M. Amela-Cortes, Y. Molard, S. Cordier, G. Dollo

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)


We evaluate poly (D,L-lactide-co-glycolide) (PLGA) nanoparticles embedding inorganic molybdenum octahedral cluster for photodynamic therapy of cancer (PDT). Tetrabutyl ammonium salt of Mo6Br14 cluster unit, (TBA)2Mo6Br14, presents promising photosensitization activity in the destruction of targeted cancer cells. Stable cluster loaded nanoparticles (CNPs) were prepared by solvent displacement method showing spherical shapes, zeta potential values around −30 mV, polydispersity index lower than 0.2 and sizes around 100 nm. FT-IR and DSC analysis revealed the lack of strong chemical interaction between the cluster and the polymer within the nanoparticles. In vitro release study showed that (TBA)2Mo6Br14 was totally dissolved in 20 min, while CNPs were able to control the release of encapsulated cluster. In vitro cellular viability studies conducted on A2780 ovarian cancer cell line treated up to 72 h with cluster or CNPs did not show any sign of toxicity in concentrations up to 20 µg/ml. This concentration was selected for photo-activation test on A2780 cells and CNPs were able to generate oxygen singlet resulting in a decrease of the cellular viability up to 50%, respectively compared to non-activated conditions. This work presents (TBA)2Mo6Br14 as a novel photosensitizer for PDT and suggests PLGA nanoparticles as an efficient delivery system intended for tumor targeting.
Original languageEnglish
Pages (from-to)95-105
Number of pages11
JournalEuropean Journal of Pharmaceutics and Biopharmaceutics
Publication statusPublished - 01 Apr 2018
Externally publishedYes


  • Molybdenum cluster
  • Ovarian cancer cell line A2780
  • PLGA nanoparticle
  • Photodynamic therapy


Dive into the research topics of 'Molybdenum cluster loaded PLGA nanoparticles: An innovative theranostic approach for the treatment of ovarian cancer'. Together they form a unique fingerprint.

Cite this